Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Evans

Showing results (431-440 of 489) with videos related to

Pageof 49
Sort By:
The Lancet. Global Health|August 9, 2014
Reassessing the value of vaccinesTill Bärnighausen, Seth Berkley, Zulfiqar A Bhutta, et al.
BMJ Mental Health|September 15, 2023
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELYOrla Macdonald, Amelia Green, Alex Walker, et al.
Chemical Science|June 24, 2021
Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo-PrP<sup>C</sup> binding and downstream pathwaysJames D Grayson, Matthew P Baumgartner, Cleide Dos Santos Souza, et al.
Lancet (London, England)|December 7, 2013
Global health 2035: a world converging within a generationDean T Jamison, Lawrence H Summers, George Alleyne, et al.
Plos Medicine|October 24, 2012
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisKatherine E Tansey, Michel Guipponi, Nader Perroud, et al.
BMJ Mental Health|April 28, 2025
Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPPChristine Cunningham, Orla Macdonald, Andrea Schaffer, et al.
The Lancet. HIV|December 14, 2020
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platformKrishnan Bhaskaran, Christopher T Rentsch, Brian MacKenna, et al.
Open Heart|November 17, 2021
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic, Helen J Curtis, Brian MacKenna, et al.
Annals of Internal Medicine|May 1, 2023
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational DataWilliam J Hulme, Elizabeth Williamson, Elsie M F Horne, et al.
The Lancet Regional Health. Europe|May 17, 2021
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platformKrishnan Bhaskaran, Sebastian Bacon, Stephen Jw Evans, et al.
Pageof 49

Showing results (431-440 of 489) with videos related to

Sort By:
Pageof 49
The Lancet. Global Health|August 9, 2014
Reassessing the value of vaccinesTill Bärnighausen, Seth Berkley, Zulfiqar A Bhutta, et al.
BMJ Mental Health|September 15, 2023
Impact of the COVID-19 pandemic on antipsychotic prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: a federated analysis of 59 million patients' primary care records in situ using OpenSAFELYOrla Macdonald, Amelia Green, Alex Walker, et al.
Chemical Science|June 24, 2021
Amyloid binding and beyond: a new approach for Alzheimer's disease drug discovery targeting Aβo-PrP<sup>C</sup> binding and downstream pathwaysJames D Grayson, Matthew P Baumgartner, Cleide Dos Santos Souza, et al.
Lancet (London, England)|December 7, 2013
Global health 2035: a world converging within a generationDean T Jamison, Lawrence H Summers, George Alleyne, et al.
Plos Medicine|October 24, 2012
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysisKatherine E Tansey, Michel Guipponi, Nader Perroud, et al.
BMJ Mental Health|April 28, 2025
Impact of the COVID-19 pandemic on antidepressant prescribing with a focus on people with learning disability and autism: an interrupted time series analysis in England using OpenSAFELY-TPPChristine Cunningham, Orla Macdonald, Andrea Schaffer, et al.
The Lancet. HIV|December 14, 2020
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platformKrishnan Bhaskaran, Christopher T Rentsch, Brian MacKenna, et al.
Open Heart|November 17, 2021
OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic, Helen J Curtis, Brian MacKenna, et al.
Annals of Internal Medicine|May 1, 2023
Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational DataWilliam J Hulme, Elizabeth Williamson, Elsie M F Horne, et al.
The Lancet Regional Health. Europe|May 17, 2021
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platformKrishnan Bhaskaran, Sebastian Bacon, Stephen Jw Evans, et al.
Pageof 49